Table 5.
Fine-Gray Competing Risks Model for COVID Death
| Variable | SHR | 95% CI | P value |
|---|---|---|---|
| Race/ethnicity | <.001 | ||
| White | 1 | ||
| Black | 2.84 | 1.38-5.82 | .004 |
| Hispanic | 3.98 | 1.94-8.20 | <.001 |
| Other | 0.80 | 0.11-5.86 | .82 |
| Age ≥65 y | 2.22 | 1.16-4.26 | .02 |
| Dialysis at follow-up | 3.40 | 1.66-6.96 | .001 |
| COVID mortality risk by state | .02 | ||
| Low | 1 | ||
| Mild | 1.09 | 0.28-4.17 | .91 |
| Moderate | 0.58 | 0.16-2.12 | .41 |
| High | 1.77 | 0.53-5.89 | .35 |
| Diabetes mellitus | 3.00 | 1.66-5.42 | <.001 |
| Ischemic cardiomyopathy | 3.41 | 1.78-6.55 | <.001 |
| LVAD at transplantation | 1.97 | 0.99-3.9 | .05 |
| Inotropes at transplantation | 2.28 | 1.15-4.51 | .02 |
| Donor history of smokinga | 2.45 | 1.33-4.54 | .004 |
COVID, coronavirus disease 2019; LVAD, left ventricular assist device; SHR, subhazard ratio.
a
More than 20 pack-years.